Costagliola S, Franssen J D F, Bonomi M, Urizar E, Willnich M, Bergmann A, Vassart G
I.R.I.B.H.M., ULB, 808 Lennik street, B-1070 Brussels, Belgium.
Biochem Biophys Res Commun. 2002 Dec 20;299(5):891-6. doi: 10.1016/s0006-291x(02)02762-6.
A Balb/c mouse was subjected to genetic immunization with a cDNA construct encoding the human thyrotropin receptor (TSHr). The immune response of the mouse resulted in the production of immunoglobulins recognizing the TSHr in three different assays: (1) flow immunocytometry (FACS) with CHO cells expressing the receptor; (2) receptor-dependent stimulation of cAMP production in the same cell line; and (3) competition with labeled TSH for binding to the receptor. One thousand hybridomas were generated from the spleen of the mouse and their supernatants were screened. A single monoclonal, IRI-SAb1, scored positive in all three assays and was studied further. It stimulated 13-fold cAMP production in TSHr-expressing CHO cells, with an EC50 in the low nanomolar range. When compared with bovine TSH, IRI-SAb1 behaved as a partial agonist. Contrary to the expectation from the characteristic of autoantibodies of Graves' patients, IRI-SAb1 recognized a linear epitope, which was localized in a segment encompassing the first 281 residues of the receptor.
用编码人促甲状腺激素受体(TSHr)的cDNA构建体对一只Balb/c小鼠进行基因免疫。小鼠的免疫反应导致在三种不同检测中产生了识别TSHr的免疫球蛋白:(1)用表达该受体的CHO细胞进行流式免疫细胞术(FACS);(2)在同一细胞系中进行受体依赖性的cAMP产生刺激;(3)与标记的促甲状腺激素竞争结合受体。从小鼠脾脏中产生了1000个杂交瘤,并对其培养上清液进行筛选。一种单克隆抗体IRI-SAb1在所有三种检测中均呈阳性,并进行了进一步研究。它在表达TSHr的CHO细胞中刺激cAMP产生增加13倍,EC50在低纳摩尔范围内。与牛促甲状腺激素相比,IRI-SAb1表现为部分激动剂。与格雷夫斯病患者自身抗体的特征预期相反,IRI-SAb1识别一个线性表位,该表位位于受体前281个残基的片段中。